InvestorsHub Logo
Post# of 251799
Next 10
Followers 829
Posts 119621
Boards Moderated 14
Alias Born 09/05/2002

Re: vinmantoo post# 242535

Wednesday, 05/18/2022 1:02:41 PM

Wednesday, May 18, 2022 1:02:41 PM

Post# of 251799
Good question. My guess is no—i.e. that ENTA will try to demonstrate that 5 days of EDP-235 is sufficient to get the job done and that this may be a point of differentiation compared to Paxlovid.

“The efficient-market hypothesis may be
the foremost piece of B.S. ever promulgated
in any area of human knowledge!”

Join the InvestorsHub Community

Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.